Company overview
Innogene Kalbiotech Pte. Ltd.
UEN
200306430D
Name
Innogene Kalbiotech Pte. Ltd.
Entity type
Local Company
Primary SSIC Description
General Trading
UEN Issue Date
8 July 2003
Secondary SSIC Description
General Trading
Status
Live Company
Incorporation date
8 July 2003
Address
21, BUKIT BATOK CRESCENT, #28-79, WCEGA TOWER
Postal Code
658065
Country
Singapore
Primary goods traded
- 💉72.5% — Blood, human or animal, antisera, other blood fractions and immunological products (300215)
- 💉23.7% — Blood, human or animal, antisera, other blood fractions and immunological products (300212)
- 💊2.9% — Medicaments (300490)
- 1.0% — Toxins, cultures of micro-organisms (excluding yeasts) and similar products (300290)
Main Trading Partners
| Partner | Type | Total Value | Percentage |
|---|---|---|---|
| PT Kalbe Farma | buyer | $18,922,602 | 34.78% |
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Trade Data
| Data Source | HS Code | Description | Buyer | Buyer Country | Seller | Seller Country | ||
|---|---|---|---|---|---|---|---|---|
| 19 December 2019 | ID | 30021500 | Rituxikal 500 Mg, Bn.11927,11929,11969, Jml: 3840 Vl Mk190283 | Kalbe International | ID | Innogene Kalbiotech Pte Limited | SG | $1,209,600.00 |
| 8 July 2025 | ID | 30021500 | Herzemab(trastuzumab 440 Mg)-Trastuzumab Combipack(with Bwfi),bn: Bf25000538 | Kalbe Farma | ID | Innogene Kalbiotech Pte Limited | $1,036,415.00 | |
| 11 October 2022 | ID | 30021500 | Herzemab(trastuzumab 440 Mg)-Trastuzumab Combipack(with Bwfi),bn: Bf22002682, Jml:2016 Box Mk220153 | Kalbe International | ID | Innogene Kalbiotech Pte Limited | IN | $745,880.00 |
| 27 December 2021 | ID | 30021500 | Herzemab (Trastuzumab 440 Mg)-Trastuzumab Combipack(with Bwfi),bn:bf21003870, Jml:2016 Box Mk210171,210245 | Kalbe International | ID | Innogene Kalbiotech Pte Limited | $624,960.00 | |
| 3 June 2023 | ID | 30021500 | Herzemab(trastuzumab 440 Mg)-Trastuzumab Combipack(with Bwfi),bn: Bf23000244, Jml:2016 Box Mk220316 | Kalbe International | ID | Innogene Kalbiotech Pte Limited | $614,880.00 | |
| 28 March 2023 | ID | 30021500 | Herzemab(trastuzumab 440 Mg)-Trastuzumab Combipack(with Bwfi),bn: Bf22006000, Jml:2016 Box Mk220271 | Kalbe International | ID | Innogene Kalbiotech Pte Limited | $614,880.00 | |
| 2 July 2024 | ID | 30021500 | Herzemab(trastuzumab 440 Mg)-Trastuzumab Combipack(with Bwfi),bn: Bf24000541, Jml: 2016 Box | Kalbe International | ID | Innogene Kalbiotech Pte Limited | $614,880.00 | |
| 27 March 2024 | ID | 30021500 | Herzemab(trastuzumab 440 Mg)-Trastuzumab Combipack(with Bwfi),bn: Bf23007032, Jml:2016 Box | Kalbe International | ID | Innogene Kalbiotech Pte Limited | $614,880.00 | |
| 11 June 2024 | ID | 30021500 | Herzemab(trastuzumab 440 Mg)-Trastuzumab Combipack(with Bwfi),bn: Bf24000541, Jml: 2016 Box | Kalbe International | ID | Innogene Kalbiotech Pte Limited | $614,880.00 | |
| 4 July 2022 | ID | 30021500 | Herzemab(trastuzumab 440 Mg)-Trastuzumab Combipack(with Bwfi),bn:bf22000879,130,89,jml:2016 Box Mk220058 | Kalbe International | ID | Innogene Kalbiotech Pte Limited | $614,880.00 |
0 of 20 row(s) selected.